KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Cash from Investing Activities (2016 - 2025)

Amgen (AMGN) has 17 years of Cash from Investing Activities data on record, last reported at -$693.0 million in Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 72.39% year-over-year to -$693.0 million; the TTM value through Dec 2025 reached -$1.9 billion, down 85.76%, while the annual FY2025 figure was -$1.9 billion, 85.76% down from the prior year.
  • Cash from Investing Activities reached -$693.0 million in Q4 2025 per AMGN's latest filing, down from -$414.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $1.4 billion in Q1 2023 and bottomed at -$27.1 billion in Q4 2023.
  • Average Cash from Investing Activities over 5 years is -$1.7 billion, with a median of -$264.5 million recorded in 2022.
  • Peak YoY movement for Cash from Investing Activities: plummeted 1410.0% in 2022, then soared 1323.42% in 2023.
  • A 5-year view of Cash from Investing Activities shows it stood at -$230.0 million in 2021, then tumbled by 1410.0% to -$3.5 billion in 2022, then plummeted by 679.99% to -$27.1 billion in 2023, then skyrocketed by 98.52% to -$402.0 million in 2024, then tumbled by 72.39% to -$693.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were -$693.0 million in Q4 2025, -$414.0 million in Q3 2025, and -$389.0 million in Q2 2025.